This article describes the results of a study from the University of California San Francisco. It highlights one of the topics Dr. Micheal Stubblefield mentioned in his presentation at our conference. It comes from a paper that was published in the British Medical Journal Supportive and Palliative Care, July 2022. First author Steven W. Cheung, MD notes the marked incidence of hearing loss and tinnitus in survivors, owing to chemotherapy drugs that contained platinum as well as those that contained taxanes.

Cardiovascular screening is critical for Hodgkin Lymphoma survivors. Anthracyclines and radiation put childhood cancer survivors at higher risk for heart failure and heart disease.

Long-term survivors have been using the internet to understand their Late Effects for years. The value of self-advocacy is highlighted in this article.

​More cancer patients live longer. Few get the help they need to stay healthy. 50-year Hodgkin Lymphoma survivor, Susan Leigh, describes the challenges of long-term cancer survivors.

A wonderful history of the “War on Cancer” and includes several quotes from Dr. Vincent DeVita–one of our Hodgkin lymphoma heroes! Also mentioned in the article is our “own” Susie Leigh, fellow long-term Hodgkin lymphoma survivor.

Here is a great article on managing stress and anxiety as a cancer survivor – not just during treatment, but afterward.

Here is a brief and straightforward article on the importance of speaking up as a cancer survivor. The author brings home the point that survivors should not expect others, including providers and caretakers, to instinctively understand what our needs and concerns are. It’s OK to use your voice and make them explicit!

In this issue of the Journal, de Vries and colleagues examine the cause-specific late mortality among a multi-center Dutch cohort of Hodgkin lymphoma survivors.